Table 4.
Postoperative oncologic outcomes: Pathological characteristics
Variable | Groups (median) | Q1–Q3 |
---|---|---|
Prostate weight (g) | 46 | 38–57 |
Pathology Gleason score | Frequency (n=640) | Rate |
| ||
6 | 111 | 17.3% |
7 | 465 | 72.7% |
8 | 40 | 6.3% |
9 | 22 | 3.4% |
10 | 2 | 0.3% |
| ||
Pathological staging | Frequency (n=635) | Rate |
| ||
pT2a | 114 | 18.0% |
pT2b | 331 | 52.1% |
pT3a | 157 | 24.7% |
pT3b | 32 | 5.0% |
pT4 | 1 | 0.2% |
| ||
Positive surgical margin | 168/638 | 26.3% |
pT2 | 81/442 | 18.3% |
pT2a | 18/111 | 16.2% |
pT2b | 63/331 | 19.0% |
pT3 | 87/189 | 46.0% |
pT3a | 66/157 | 42.0% |
pT3b | 21/3 | 65.6% |